Improving Engagement While Maintaining Data Integrity & Validity
In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Associate Editor, Miranda Schmalfuhs, and uMotif's Chief Product Officer, Julia Lakeland, discuss:
- What kinds of technologies can be developed to improve patient engagement and reduce the emotional and logistical burdens of participation—while maintaining data integrity and validity
- How new technologies can personalize the clinical trial experience for diverse patient populations, considering factors like age, access to resources, and cultural needs—while still ensuring inclusivity and equitable access to participation
- Ethical considerations that need to be addressed when developing and implementing new technologies for collecting and analyzing patient data in clinical trials—while still ensuring patient privacy, data security, and informed consent
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on Spotify and Google Podcasts
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
